Latest News

Reinsurance Group of America: Recent Performance Snapshot Reinsurance Group of America (RGA) has drawn investor attention after a period of strong share price performance, with the stock showing positive returns over the past week, month, past 3 months, and year to date. See our latest analysis for Reinsurance Group of America. The recent 9.4% 1 day share price return, on top of a 21.23% 3 month share price return and a 122.00% 5 year total shareholder return, points to momentum that has been...

In February 2026, Mitsubishi Heavy Industries reported nine‑month sales of ¥3,326,976 million and net income of ¥210,996 million, and raised its full‑year fiscal 2025–26 earnings guidance, while also announcing multiple executive and board changes effective from March 31 and April 1, 2026. The reshuffle places new executive vice presidents in charge of Energy Systems, Nuclear Energy Systems, and Commercial Aviation Systems, signaling internal emphasis on these core business segments...

Why Church & Dwight is on investors’ radar today Church & Dwight (CHD) has drawn fresh attention after recent trading left the stock around $100.53, with short term returns ranging from roughly flat over the past day to gains in the past month. See our latest analysis for Church & Dwight. The recent 17.2% one-month share price return and 21.65% year-to-date share price return suggest momentum has picked up, even though the one-year total shareholder return is slightly negative at 2.63%, with...

If you are wondering whether monday.com at around US$98 a share is starting to look interesting, you are not alone in asking what you are really paying for today. The stock has seen sharp moves recently, with a 13.1% decline over the last 7 days, 33.8% over 30 days, 31.7% year to date and 70.0% over the past year. This changes how many investors might view its risk and potential reward. These price moves have come as monday.com continues to sit in the spotlight of work management and...

Cytokinetics stock overview Cytokinetics (CYTK) has drawn fresh attention after recent share price moves, prompting investors to reassess how its late stage muscle focused drug pipeline and current financial profile line up with their risk appetite. See our latest analysis for Cytokinetics. At a share price of $62.34, Cytokinetics has seen a 3.49% 1 day share price return but softer recent momentum, with a 90 day share price return decline of 6.26%. However, the 1 year total shareholder...

In early February 2026, Datadog drew attention as analysts highlighted strong demand for its observability platform amid macro uncertainty and tighter enterprise IT budgets. At the same time, fresh concerns emerged that new AI models from Anthropic and OpenAI could eventually displace traditional monitoring software, raising questions about how resilient Datadog’s business model may be to AI-driven automation. Next, we’ll examine how rising fears that AI agents could replace traditional...

Capcom Co., Ltd. reported earnings for the nine months ended December 31, 2025, with sales of ¥115,315 million and net income of ¥38,885 million, both higher than the prior-year period. The rise in basic earnings per share from continuing operations to ¥92.96, up from ¥55.15 a year earlier, highlights stronger profitability per share for investors to assess. We will now examine how Capcom’s stronger earnings per share profile could influence the company’s broader investment narrative and...

CAR Group (ASX:CAR) has put another solid set of numbers on the table for H1 2026, with trailing twelve month revenue of A$1.2 billion and basic EPS of A$0.78, backed by net income of A$295.4 million. The company has seen revenue move from A$567.8 million in H2 2024 to A$579.4 million in H1 2025 and A$604.4 million in H2 2025, while basic EPS stepped from A$0.35 to A$0.33 and then A$0.40 over the same periods. This sets up the latest result against a backdrop of expanding net margins and...

CIBC Asset Management received seven FundGrade A+ Awards for 2024, recognizing excellence across several mutual funds. The awards highlight the performance and capabilities of Canadian Imperial Bank of Commerce’s asset management arm. This recognition may be relevant for clients and investors assessing TSX:CM’s role in the Canadian investment fund market. For Canadian Imperial Bank of Commerce (ticker TSX:CM), these FundGrade A+ Awards put fresh attention on its asset management franchise...

QCR Holdings, Inc. recently reported full-year 2025 results showing higher net interest income of US$255.22 million and net income of US$127.19 million, alongside increased earnings per share from continuing operations versus 2024. The company also maintained stable quarterly net charge-offs of US$4.2 million and completed a share repurchase of 149,456 shares for US$11.6 million, signaling management’s ongoing focus on asset quality and capital return. Next, we’ll examine how QCR Holdings’...

Ciena (NYSE:CIEN) has been added to several flagship S&P indices, including the S&P 500 and S&P Global 1200. The index changes reflect a shift in Ciena's market profile and are tied to recent updates in index compositions. Alongside the index additions, Ciena recently announced high impact network deployments for major clients in Europe and the Asia Pacific region. Ciena is a networking systems, services, and software company, with a focus on high capacity optical and IP infrastructure that...

If you are wondering whether Bio-Techne is attractively priced or just fairly valued right now, you are in the right place to put some structure around that question. Bio-Techne's share price last closed at US$66.78, with returns of 2.3% over 7 days, 1.6% over 30 days, 12.0% year to date, but a 3.9% decline over 1 year, a 12.2% decline over 3 years and a 31.7% decline over 5 years. Recent attention on the stock has been shaped by ongoing interest in life sciences tools companies and how...

The latest move from Hongkong Land Holdings (SGX:H78), the launch of its S$8.2b Singapore Central Private Real Estate Fund alongside an expanded share buyback programme, puts capital recycling and shareholder returns firmly in the spotlight for investors. See our latest analysis for Hongkong Land Holdings. The recent SCPREF launch and expanded buyback sit alongside a strong run in the shares. The $8.37 price comes after a 39.5% 3 month share price return and a 1 year total shareholder return...

Mapletree Pan Asia Commercial Trust (SGX:N2IU) has just released its third quarter and nine month earnings, along with a fresh distribution per unit update, giving investors new numbers on income, sales and upcoming payouts. See our latest analysis for Mapletree Pan Asia Commercial Trust. At a share price of SGD1.46, the trust has seen a 1 day share price return of 1.39%. The 90 day share price return of a 1.35% decline contrasts with a 1 year total shareholder return of 30.17%. This suggests...

Event-driven snapshot of Aktis Oncology Aktis Oncology (AKTS) has drawn investor attention after recent trading, with the stock closing at US$18.98 and showing negative returns over the past week, month and year to date. See our latest analysis for Aktis Oncology. The recent 1 day share price return of a 3.01% decline, alongside 7 day and year to date share price returns of 13.65% and 15.27% declines, points to fading short term momentum after earlier optimism. Current moves likely reflect...

The board of Universal Corporation ( NYSE:UVV ) has announced that it will pay a dividend on the 4th of May, with...

As the Canadian market navigates a landscape influenced by global tech repricing and AI-driven capital expenditures, investors are reevaluating their strategies. Penny stocks, though an old term, still represent smaller or emerging companies that can offer intriguing opportunities for those willing to explore beyond the mainstream. By focusing on financial stability and potential growth, these stocks may present unique investment prospects in today's evolving market climate.

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

F&G Annuities & Life, founded in 1959 and serving about 677,000 policyholders, has seen very large net premium expansion over the past two years, while Wall Street currently expects strong book value per share growth over the next 12 months. These trends, alongside the company’s upcoming fourth quarter and full-year 2025 earnings release and webcast scheduled for February 19–20, 2026, are drawing increased attention to how effectively F&G converts premium growth into capital. We’ll now...

Why Sumitomo Bakelite (TSE:4203) is in focus after earnings and guidance Sumitomo Bakelite (TSE:4203) is back on investors’ radar after reporting nine month earnings to December 31, 2025, and lifting its full year fiscal 2026 guidance on stronger semiconductor materials demand. See our latest analysis for Sumitomo Bakelite. The earnings beat and upgraded guidance appear to be feeding into steady momentum, with the 1 month share price return of 8.58% and year to date share price return of...

Pagaya Technologies Ltd. ( NASDAQ:PGY ) shareholders that were waiting for something to happen have been dealt a blow...

Recent commentary on Strategic Education (STRA) focuses on a five year decline in earnings per share alongside revenue growth, subdued 4.3% domestic student expansion, and expectations for flat free cash flow margins. These factors raise questions about profitability momentum. See our latest analysis for Strategic Education. Over the past year, the share price has been relatively flat overall, with a 3.54% year to date share price return and a 16.28% decline in total shareholder return over...

In February 2026, OMV Aktiengesellschaft reported fourth-quarter 2025 sales of €6,045 million and net income of €103 million, with both quarterly and full-year figures lower than the prior year. An interesting detail for investors is the drop in full-year basic earnings per share from continuing operations to €2.41, compared with €4.05 previously, highlighting pressure on profitability. With OMV’s recent share price moves and a weaker earnings profile, we’ll examine how the compressed...